Facial erythema after the treatment of dupilumab in SLE patient

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, July 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 17,553 followers.

Facial erythema after the treatment of dupilumab in SLE patient https://t.co/xQSNvECh3M #allergy #feedly

RT @ImmunAllergyBMC: Facial erythema after the treatment of dupilumab in SLE patient https://t.co/WIbtdHL1Hu

RT @ImmunAllergyBMC: Facial erythema after the treatment of dupilumab in SLE patient https://t.co/WIbtdHL1Hu

RT @ImmunAllergyBMC: Facial erythema after the treatment of dupilumab in SLE patient https://t.co/WIbtdHL1Hu

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.